1 / 19

EEOICPA Compensation Results (through March 2004)

This report provides the completed claim results of EEOICPA compensation through March 2004, with important caveats and considerations. It includes the compensability rates for various cancer models, unknown and multiple primary claims, years worked, age at diagnosis, smoking status, and gender.

mwebber
Download Presentation

EEOICPA Compensation Results (through March 2004)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EEOICPA Compensation Results (through March 2004) Russ Henshaw, MS Epidemiologist NIOSH/Office of Compensation Analysis & Support Cincinnati, OH

  2. Completed Claim Results:Important Caveats • Results are through March 31, 2004 • Includes only those cases in which NIOSH has received notice from DOL of an official compensation decision (~ 2/3 of cases) • May NOT be predictive of future results • Unless otherwise noted, results are for claims with only one primary cancer

  3. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model

  4. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  5. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  6. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  7. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  8. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  9. Completed Claims: Proportion That Were Compensable, by NIOSH-IREP Cancer Model (Cont.)

  10. Compensability Rate, by Cancer Model (10 or More Completed Cases)

  11. Compensability Rate, by Cancer Model (10 or More Completed Cases)

  12. Compensability Rate, by Cancer Model (10 or More Completed Cases) • 0% (no compensable cases): • Esophagus • Stomach • Rectum • Pancreas • Connective tissue • Female genitalia, excluding ovary • All male genitalia • Nervous system • Thyroid

  13. Compensability Rates for “Unknown Primary” and “Multiple Primary” Claims

  14. Proportion of Claims That Were Compensable, by Years Worked

  15. Proportion of Claims That Were Compensable, by Age at Diagnosis

  16. Lung Cancer Compensability (Single Primary Cancer) by Smoking Status

  17. Lung Cancer Compensability (Single Primary Cancer) by Smoking Status

  18. Compensability Rate by Gender (All Completed Claims)

  19. Summary • Some initial surprises, but current results are skewed: • By dose reconstruction “efficiency process” • Possibly by incomplete data (we are awaiting official decisions from DOL for about 1/3 of all completed cases) • Data will continue to be monitored for trends & anomalies • Results are not predictive of future claims

More Related